Funder
Yonsei University | Yonsei University College of Medicine
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Song K, Kim HS, Chae HW. Nonalcoholic fatty liver disease and insulin resistance in children. Clin Exp Pediatr. 2023;66:512–9.
2. Kamani L, Rahat A, Yilmaz Y. Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: a call for action. Hepatol Forum. 2024;5:1–2.
3. Bansal SK, Bansal MB. Review article: Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024. https://doi.org/10.1111/apt.17930.
4. Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020. Clin Gastroenterol Hepatol. 2023. https://doi.org/10.1016/j.cgh.2023.11.003.
5. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010;138:1357–64. 64 e1-2.